Nautilus Biotechnology (NAUT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Executive summary
Annual meeting scheduled for June 17, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 16, 2026.
Voting matters and shareholder proposals
Election of two Class II directors: Parag Mallick and Farzad Nazem, with board recommendation to vote in favor.
Ratification of PricewaterhouseCoopers LLP as independent auditor for the year ending December 31, 2026.
Advisory vote on executive compensation for the fiscal year ended December 31, 2025.
Advisory vote on the frequency of future say-on-pay votes, with board recommending annual votes.
Proxyholders may vote on other business arising at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends the election of two director nominees for Class II positions.
Latest events from Nautilus Biotechnology
- Launch delayed to late 2026; net loss rose 11% to $70.8M; cash runway through 2027.NAUT
Q4 20249 Jul 2026 - Comprehensive proteomics platform targets full proteome analysis with launch planned for late next year.NAUT
Morgan Stanley 23rd Annual Global Healthcare Conference9 Jul 2026 - Operating expenses fell 14% and net loss narrowed as platform commercialization advanced.NAUT
Q1 20268 Jul 2026 - Next-gen proteomics platform set for 2025 launch, targeting deep, accessible protein analysis.NAUT
Goldman Sachs 45th Annual Global Healthcare Conference8 Jul 2026 - Q3 net loss was $16.4M, cash $221.2M, launch targeted for late 2025, milestones delayed.NAUT
Q3 20248 Jul 2026 - All proposals passed, including director elections and annual Say on Pay votes.NAUT
AGM 202617 Jun 2026 - A novel proteomics platform promises to revolutionize drug discovery and precision medicine.NAUT
Investor Summit Virtual Conference2 May 2026 - Board recommends all proposals, annual say-on-pay, and highlights strong governance and compliance.NAUT
Proxy filing28 Apr 2026 - New proteomics platform promises comprehensive, reproducible protein analysis with broad applications.NAUT
TD Cowen 46th Annual Health Care Conference2 Mar 2026